Trial Profile
Comparison of efficacy and tolerability of palonosetron administered once, twice, and three times before haemotopoietic stem cell transplantation in multiple myeloma patients receiving melphalan and dexamethasone.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Feb 2011
Price :
$35
*
At a glance
- Drugs Palonosetron (Primary)
- Indications Chemotherapy-induced nausea and vomiting
- Focus Therapeutic Use
- 09 Feb 2011 New trial record